HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema

HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema

The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.

Study: Long-Approved HIV Drug May Improve Vision in Patients with DME

A clinical trial suggests that lamivudinem, an inexpensive, long-approved HIV drug, can improve vision in patients with diabetic macular edema more effectively and at a lower cost than many existing treatments, according to researchers at the University of Virginia (UVA Health). Another potential benefit is the the drug is taken orally, offering patients an alternative to monthly injections directly into their eyes. Jayakrishna Ambati, MD, found…